Nexgel Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $12.1M+38.9% YoYTTM through 30 Jun 2026
Net Income -$6.2MTTM through 30 Jun 2026
Free Cash Flow -$3.3MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 39.5% |
| EBITDA Margin | -35.2% |
| Operating Margin | -29.4% |
| Net Margin | -51.3% |
Returns
-64.9%ROE
-27.7%ROA
Balance Sheet Health
Debt / Equity0.13x
Current Ratio1.47x
Net Debt$269K
Cash & Equivalents$938K
Quality Metrics
Altman Z-Score-1.87
Piotroski F-Score4 / 9
FCF Margin-27.1%
Earnings-Beat Rate0.0%
Multi-Year Trend
RevenueFY2025: $11.4M
Diluted EPS-$0.74TTMFY2025: $-0.38
Dividend
No dividend
Capital Allocation
R&D Spend$21K
Capex Intensity0.6%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.